Table of Content

1 Study Coverage
1.1 Therapeutic Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Therapeutic Vaccines Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Therapeutic Vaccines Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Therapeutic Vaccines Market by Region
1.4.1 Global Therapeutic Vaccines Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Therapeutic Vaccines Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Therapeutic Vaccines Revenue by Players
2.1.1 Global Therapeutic Vaccines Revenue by Players (2019-2024)
2.1.2 Global Therapeutic Vaccines Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Therapeutic Vaccines Revenue in 2024
2.2 Global Therapeutic Vaccines Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Therapeutic Vaccines Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Valeant Pharmaceuticals
3.1.1 Valeant Pharmaceuticals Information
3.1.2 Valeant Pharmaceuticals Overview
3.1.3 Valeant Pharmaceuticals Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.1.4 Valeant Pharmaceuticals Related Developments
3.2 BioVex Inc
3.2.1 BioVex Inc Information
3.2.2 BioVex Inc Overview
3.2.3 BioVex Inc Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.2.4 BioVex Inc Related Developments
3.3 Inovio Pharmaceuticals Inc
3.3.1 Inovio Pharmaceuticals Inc Information
3.3.2 Inovio Pharmaceuticals Inc Overview
3.3.3 Inovio Pharmaceuticals Inc Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.3.4 Inovio Pharmaceuticals Inc Related Developments
3.4 Immunocellular Therapeutics Ltd
3.4.1 Immunocellular Therapeutics Ltd Information
3.4.2 Immunocellular Therapeutics Ltd Overview
3.4.3 Immunocellular Therapeutics Ltd Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.4.4 Immunocellular Therapeutics Ltd Related Developments
3.5 Agenus Inc
3.5.1 Agenus Inc Information
3.5.2 Agenus Inc Overview
3.5.3 Agenus Inc Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.5.4 Agenus Inc Related Developments
3.6 GlaxoSmithKline plc
3.6.1 GlaxoSmithKline plc Information
3.6.2 GlaxoSmithKline plc Overview
3.6.3 GlaxoSmithKline plc Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.6.4 GlaxoSmithKline plc Related Developments
3.7 Pfizer Inc.
3.7.1 Pfizer Inc. Information
3.7.2 Pfizer Inc. Overview
3.7.3 Pfizer Inc. Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.7.4 Pfizer Inc. Related Developments
3.8 Novartis AG
3.8.1 Novartis AG Information
3.8.2 Novartis AG Overview
3.8.3 Novartis AG Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.8.4 Novartis AG Related Developments
3.9 Argos Therapeutics
3.9.1 Argos Therapeutics Information
3.9.2 Argos Therapeutics Overview
3.9.3 Argos Therapeutics Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.9.4 Argos Therapeutics Related Developments
3.10 Bavarian Nordic
3.10.1 Bavarian Nordic Information
3.10.2 Bavarian Nordic Overview
3.10.3 Bavarian Nordic Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.10.4 Bavarian Nordic Related Developments
3.11 Transgene
3.11.1 Transgene Information
3.11.2 Transgene Overview
3.11.3 Transgene Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.11.4 Transgene Related Developments
3.12 Galena Biopharma and Vaccinogen Inc
3.12.1 Galena Biopharma and Vaccinogen Inc Information
3.12.2 Galena Biopharma and Vaccinogen Inc Overview
3.12.3 Galena Biopharma and Vaccinogen Inc Therapeutic Vaccines Revenue and Gross Margin (2019-2024)
3.12.4 Galena Biopharma and Vaccinogen Inc Related Developments
4 Global Therapeutic Vaccines Market Insights
4.1 Global Therapeutic Vaccines Market Revenue 2019-2024
4.2 Global Therapeutic Vaccines Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Therapeutic Vaccines Revenue by Type
5.2 Global Therapeutic Vaccines Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Therapeutic Vaccines Revenue by Application
6.2 Global Therapeutic Vaccines Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Therapeutic Vaccines Market Size by Type
7.1.1 Americas Therapeutic Vaccines Revenue by Type (2019-2024)
7.1.2 Americas Therapeutic Vaccines Revenue Share by Type (2019-2024)
7.2 Americas Therapeutic Vaccines Market Size by Application
7.2.1 Americas Therapeutic Vaccines Revenue by Application (2019-2024)
7.2.2 Americas Therapeutic Vaccines Revenue Share by Application (2019-2024)
7.3 Americas Therapeutic Vaccines Market Size by Country
7.3.1 Americas Therapeutic Vaccines Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Therapeutic Vaccines Market Size by Type
8.1.1 Europe Therapeutic Vaccines Revenue by Type (2019-2024)
8.1.2 Europe Therapeutic Vaccines Revenue Share by Type (2019-2024)
8.2 Europe Therapeutic Vaccines Market Size by Application
8.2.1 Europe Therapeutic Vaccines Revenue by Application (2019-2024)
8.2.2 Europe Therapeutic Vaccines Revenue Share by Application (2019-2024)
8.3 Europe Therapeutic Vaccines Market Size by Country
8.3.1 Europe Therapeutic Vaccines Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Therapeutic Vaccines Market Size by Type
9.1.1 Asia Pacific Therapeutic Vaccines Revenue by Type (2019-2024)
9.1.2 Asia Pacific Therapeutic Vaccines Revenue Share by Type (2019-2024)
9.2 Asia Pacific Therapeutic Vaccines Market Size by Application
9.2.1 Asia Pacific Therapeutic Vaccines Revenue by Application (2019-2024)
9.2.2 Asia Pacific Therapeutic Vaccines Revenue Share by Application (2019-2024)
9.3 Asia Pacific Therapeutic Vaccines Market Size by Region
9.3.1 Asia Pacific Therapeutic Vaccines Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Vaccines Market Size by Type
10.1.1 Middle East and Africa Therapeutic Vaccines Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Therapeutic Vaccines Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Therapeutic Vaccines Market Size by Application
10.2.1 Middle East and Africa Therapeutic Vaccines Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Therapeutic Vaccines Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Therapeutic Vaccines Market Size by Country
10.3.1 Middle East and Africa Therapeutic Vaccines Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Therapeutic Vaccines Industry Trends
11.2 Therapeutic Vaccines Market Drivers
11.3 Therapeutic Vaccines Market Challenges
11.4 Therapeutic Vaccines Market Restraints
12 Therapeutic Vaccines Forecasted Market Size by Type
12.1 Global Therapeutic Vaccines Forecasted Revenue by Type
12.2 Global Therapeutic Vaccines Forecasted Market Size Growth by Type 2024-2030
13 Therapeutic Vaccines Forecasted Market Size by Application
13.1 Global Therapeutic Vaccines Forecasted Revenue by Application
13.2 Global Therapeutic Vaccines Forecasted Market Size Growth by Application 2024-2030
14 Global Therapeutic Vaccines Market Forecasts
14.1 Global Therapeutic Vaccines Market Revenue Forecasts 2024-2030
14.2 Global Therapeutic Vaccines Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Therapeutic Vaccines Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Therapeutic Vaccines Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Therapeutic Vaccines Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Therapeutic Vaccines Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer